Jain Global LLC Astrazeneca PLC Transaction History

Jain Global LLC

$19.5 Billion
Q3 2025

A detailed history of Jain Global LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jain Global LLC holds 4,450 shares of AZN stock, worth $397,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,450

Holding current value

$397,830

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $305,804 - $365,389	4,450 New	4,450 $341,000
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $2.8 Million - $3.34 Million	42,834 New	42,834 $3.15 Million

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

501M

Call Options Held

5.59M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.

Account